Citi Upgrades Rigel Pharmaceuticals (RIGL) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. TJX
10. DE

February 22, 2012 7:50 AM EST
Get Alerts RIGL Hot Sheet
Price: $45.20 -3.75%

Rating Summary:
    5 Buy, 8 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Citi upgraded Rigel Pharmaceuticals (NASDAQ: RIGL) from Neutral to Buy with a price target of $13.00.

For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.

Shares of Rigel Pharmaceuticals closed at $9.35 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Citi